Floatz logo

CYCLOSPORIN A

Chronic Myelogenous Leukemia

Fred Hutchinson Cancer Centerprotein_peptidePhase 3Active
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
81/ 100

Competitive context

85 Active assets in the Chronic Myelogenous Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 3BBB
Nilotinib
Novartis Pharmaceuticals
Phase 4BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BBB
Romidepsin
Center for International Blood and Marrow Transplant Research
Phase 2BBB
Therapeutic Allogeneic Lymphocytes
University of Chicago
Phase 2BBB

View all 50 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →